JNCCN Names New Editor-in-Chief

FORT WASHINGTON, Pa., July 10, 2008 — The Journal of the National Comprehensive Cancer Network (JNCCN) has named Harold J. Burstein, MD, PhD, as its new editor-in-chief. Dr. Burstein will lead and set the direction of the journal as well as serve as the ambassador for JNCCN in the oncology community.

Dr. Burstein is a medical oncologist specializing in the treatment of breast cancer at the Dana-Farber Cancer Institute in Boston and an Associate Professor of Medicine at Harvard Medical School. A recognized leader in breast cancer care and clinical research, Dr. Burstein serves as member of several national committees, including the NCCN Breast Cancer Guidelines Panel.

JNCCN is a peer-reviewed, indexed medical journal providing the latest information about optimal clinical practices, oncology outcomes, and new research initiatives. It is currently ranked seventh in readership among the top oncology publications, according to FOCUS, a leading readership-measurement company for medical journals.

“The appointment of Dr. Burstein as the new Editor-in-Chief of JNCCN will assure that the journal will further increase and enhance its scientific and clinical content, readership and esteem in the world of oncology,” said Bill McGivney, PhD, CEO of the NCCN.

JNCCN is a controlled circulation publication distributed to more than 20,000 oncologic subspecialists, including medical and radiation oncologists, hematologists, oncologic surgeons, advanced practice nurses, etc. More information about the journal can be found at www.nccn.org.